Aclaris Therapeutics Inc (ACRS)
EBITDA Growth
-27.41%
Quarterly · Period ending:
ACRS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-27.41%period ending
Latest reported-27.41%period ending
ACRS Quarterly EBITDA YoY % (-60.96% → -27.41%)
Year-over-year change
High-resolution chart · PNG
ACRS ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -27.4146% | |
| -11.7014% | |
| -41.4016% | |
| -52.8024% | |
| -35.3045% | |
| -11.1279% | |
| 40.9623% | |
| 67.6758% | |
| 61.3044% | |
| 47.9423% | |
| -8.2656% | |
| -58.8929% | |
| -32.6112% | |
| -53.3745% | |
| -6.3085% | |
| 3.7648% | |
| -86.6502% | |
| -68.607% | |
| -51.1504% | |
| -107.6557% | |
| -20.2691% | |
| 10.3396% | |
| 22.0914% | |
| 56.4431% | |
| 51.5077% | |
| 46.9768% | |
| 53.7015% | |
| -0.5398% | |
| 28.0976% | |
| 19.7848% | |
| -50.4623% | |
| -13.294% | |
| -109.0442% | |
| -140.2795% | |
| -118.4958% | |
| -72.9128% | |
| -14.0488% | |
| 1.9712% | |
| -135.3365% | |
| -1.6214% | |
| -403.5742% | |
| -400.3427% | |
| -86.9565% | |
| -298.947% | |
| -57.7689% | |
| -60.9562% |